Nucleon Inc. - Case Solution
The case study depicts Nucleon, a small biotechnology venture, whose first potential product is about to enter clinical testing. However, before the company can start clinical tests, its management needs to decide where and how to produce the product. Three options are being considered.
Case Questions Answered
- Which combination of options should Nucleon Inc. choose and why?
This case solution includes an Excel file with calculations that will be available after purchase.
This case solution includes an Excel file with calculations.
Which combination of options should Nucleon Inc. choose and why?
Nucleon Inc.’s management should choose to license its products immediately. Given the high capital costs of either a pilot plant or a full-scale FDA- approved manufacturing facility, the likelihood of failure in the experimental drug industry, and given that licensing results in immediate cash and zero future outlay, “Option 5” provides a safer yet very profitable future.
NPV
Strictly from a net present value point-of-view, Licensing has several advantages.
First, Exhibit 1 shows that Option 5 has the highest NPV of all the options for Nucleon Inc. in the short term (through 2002), besting the next-highest NPV project by nearly a factor of two.
Secondly, in the long term (through 2009), it still manages a positive NPV but drops to 3rd out of the five choices.
While Option 1 (Build/Build) exhibits a very high long-term NPV of over $7 million, the other options overshadow it. Option 3 (Buy/Build) has a higher NPV both in the short term and long term and requires less capital outlay (reducing risk) for Nucleon Inc.
Similar to Option 1, Option 2 (Build/Buy) is…
Complete Case Solution
Get immediate access to the full, detailed analysis
- Comprehensive answers to all case questions
- Detailed analysis with supporting evidence
- Instant digital delivery (PDF format)
Secure payment • Instant access
By clicking, you agree to our Terms of Use, Arbitration and Class Action Waiver Agreement and Privacy Policy